Zydus Life gets Mexico regulator's nod to market cancer treatment drug - CNBC TV18
Zydus Lifesciences on Monday, July 22, said it has received approval from the Mexico regulator COFEPRIS to market Bhava, which will be used to treat various cancers. Bhava is a Bevacizumab biosimilar ...
CNBC TV18
30 minutes ago